Imaging biofilms in three dimensions: modalities, quantitative readouts, and the path to four-dimensional measurement

Biofilms are spatially structured microbial communities whose architecture, chemistry, mechanics, and cellular states evolve over time. Bulk assays and two-dimensional projections remain useful but cannot resolve how these properties vary with depth or during growth, treatment, dispersal, and regrowth. Imaging offers complementary routes to three-dimensional measurement: fluorescence microscopy provides molecular, taxonomic, and functional specificity; optical coherence tomography resolves mesoscale architecture and dynamics; quantitative phase imaging and holotomography report refractive index and biomass-related changes; Raman methods provide chemical and metabolic contrast; and Brillouin microscopy probes mechanical response. We compare these modalities using four independent descriptors-contrast provenance, live volumetric capability, perturbation, and demonstrated biofilm use-and relate their signals to quantitative biological readouts. Modality selection depends on the spatial scale, sampling rate, specificity, and perturbation acceptable for the biological question. Longitudinal imaging links changes in architecture to molecular and functional measurements when the channels are registered and their signals validated. We therefore frame four-dimensional biofilm measurement as an integrated architecture combining a low-perturbation volumetric backbone with spatially registered molecular measurements acquired continuously or at predefined validation points. This integration requires compatible cultivation formats, a controlled imaging dose, shared quantitative parameters, and cross-modality registration.